Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: CD derivatives

January 12, 2026 CD as API / CD derivatives / Drug delivery / Non-pharma applications / Pharma applications / Uncategorized

Special Issue of the 21st International Cyclodextrin Symposium

The papers from the Special Issue of the 21st International Cyclodextrin Symposium published in Carbohydrate Polymers are available (https://www.sciencedirect.com/special-issue/10BLTS8S758).  The

Continue reading

January 6, 2026 CD as API / CD derivatives / Pharma applications

Sulfonated, sulfated thioglycosides and multivalence in heparanase inhibition

Heparan sulfate (HS) analogs are synthetic oligo- and polysaccharides designed to mimic or enhance several biological properties of native HS.

Continue reading

December 23, 2025 CD as API / CD derivatives / Pharma applications

Multifunctional biomimetic nanocarriers for the treatment of atherosclerosis

Atherosclerosis (AS) has been considered a systemic disease characterized by the excessive generation of reactive oxygen species (ROS) and the

Continue reading

December 19, 2025 CD derivatives / Pharma applications

Cyclodextrin-based carriers for targeted drug delivery, a new review

This post was written by Ibrahim Hussein. Cyclodextrin-based carriers have evolved beyond their traditional role as solubilizing agents toward ligand-targeted,

Continue reading

a rat is standing on top of a plastic container
December 18, 2025 CD as API / CD derivatives / Pharma applications

Selective removal of 7-ketocholesterol by a CD-dimer, a novel atherosclerosis therapeutic candidate

The removal of the toxic oxidized cholesterol, 7-ketocholesterol (7KC), from cells through the administration of therapeutics has the potential to

Continue reading

December 15, 2025 CD as API / CD derivatives / Pharma applications

Dual activity of low-molecular-weight polymeric β-cyclodextrins against tuberculosis

/The biological properties of pβCD of different molecular weights were studied. Strikingly, only the low-molecular-weight pβCD (LMW-pβCD) displayed antibacterial activity,

Continue reading

December 4, 2025 CD derivatives / Drug delivery / Pharma applications

Novel delivery systems for Resveratrol

A novel polymer, β-cyclodextrin-epichlorohydrin-cyanoguanidine polymer (CDPC) was synthesized to evaluate its potential as an efficient carrier for the encapsulation of

Continue reading

european commission flags on poles
December 2, 2025 CD derivatives / Pharma applications

First EMA regulation on the residues of betadex sulfobutylether sodium in foodstuffs of animal

Regulation (European Commission) No. 470/2009 lays down Community procedures for the establishment of residue limits of pharmaceutical active substances, excipients

Continue reading

December 1, 2025 CD as API / CD derivatives / Drug delivery / Pharma applications

From an Idea to a Journey: My Path Toward Treating Gout and Hyperuricemia With Cyclodextrins

When I look back at the last few years, it’s hard not to feel moved by what this project has

Continue reading

a rat is standing on top of a plastic container
November 24, 2025 CD as API / CD derivatives / Pharma applications

A β-cyclodextrin polymer reduces cholesterol accumulation and mitigates autophagy dysfunction in vitro and in a Niemann–Pick Type C animal model

Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are both characterised by cognitive decline and neurological impairment. In each

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 … 40 Next Posts»

Recent Posts

  • HPβCD’s Promise in Treating Ischemic Stroke
  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (63)
  • CD as API (340)
  • CD derivatives (395)
  • Cosmetics and toilettry (49)
  • Diagnosis (11)
  • Drug delivery (774)
  • E-ducation (63)
  • Environmental (129)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (390)
  • Other industrial use (104)
  • Pharma applications (1,157)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • HPβCD's Promise in Treating Ischemic Stroke
  • Oculis: eye drops with Dexamethasone/gamma-CD complex Phase 3 study concluded soon
  • Lanosterol eye drops for cataract treatment
  • Flame-Resistant 3D Printing with Cyclodextrin: A Hewlett-Packard Patent Application
  • Sun-protective clothing using benzophenone/CD complex
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Minimizing tissue reactions with cyclodextrins at infusion site of insulin therapy
  • Does Vinblastine Retain its Anticancer Effect in the Presence of Cyclodextrin? A Preliminary Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...